Cullinan Therapeutics Inc.

CGEM | NASDAQ

Price Alert Chart Builder DCF Calculator

$21.50

+$0.15 (+0.70%)

Sep 22, 2026, 10:51 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	18.94M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	77K	76K	77K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-77K	-76K	-77K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	18.94M
Operating Income	-57.25M	-53.7M	-55.26M	-55.6M	-75.8M	-55M	-55.05M	-48.86M	-50.03M	-42.99M	-45.49M	-45.24M	-37.61M	-62.76M	-32.61M	-29.77M	239.68M	-32.66M	-34.35M	-18.38M	-16.6M	1.37M
Interest Income	3.65M	4.1M	4.62M	5.09M	5.92M	6.58M	7.51M	8.38M	8.07M	5.69M	5.92M	5.88M	5.32M	4.51M	3.36M	2.35M	697K	197K	137K	118K	173K	49K
Pretax Income	-53.7M	-49.66M	-50.71M	-50.61M	-70.06M	-48.5M	-47.53M	-40.56M	-42.03M	-37.34M	-39.69M	-39.18M	-32.21M	-58.14M	-28.95M	-27.41M	240.14M	-32.46M	-34.21M	-18.26M	-16.44M	1.42M
Net Income	-53.7M	-49.66M	-50.71M	-50.61M	-70.06M	-48.5M	-47.65M	-40.56M	-42.03M	-37.15M	-23.8M	-39.18M	-32.21M	-57.96M	-26.78M	-24.8M	174.9M	-12.1M	-32.51M	-17.35M	-15.64M	-70K
Selling & General & Admin	12.82M	11.57M	12.31M	13.63M	14.77M	13.54M	14.56M	13.35M	13.69M	12.27M	10.56M	10.98M	10.21M	10.66M	11.29M	10.09M	10.7M	8.12M	13.47M	5.7M	4.83M	5.16M
Research & Development	44.44M	42.12M	42.95M	41.97M	61.03M	41.46M	40.49M	35.51M	36.26M	30.65M	34.85M	33.82M	27.39M	52.1M	21.32M	19.68M	26.41M	24.54M	20.88M	12.68M	11.78M	12.42M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	440K	n/a	n/a	n/a	n/a	-276.79M	n/a	n/a	n/a	n/a	-2K
Operating Expenses	57.25M	53.7M	55.26M	55.6M	75.8M	55M	55.05M	48.86M	49.95M	42.91M	45.41M	45.24M	37.61M	62.76M	32.61M	29.77M	-239.68M	32.66M	34.35M	18.38M	16.6M	17.57M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-77K	-76K	-77K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	57.25M	53.7M	55.26M	55.6M	75.8M	55M	55.05M	48.86M	50.03M	42.99M	45.49M	45.24M	37.61M	62.76M	32.61M	29.77M	-239.68M	32.66M	34.35M	18.38M	16.6M	17.57M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	117K	n/a	n/a	n/a	-14.12M	n/a	n/a	n/a	-1.86M	-2.52M	66.07M	-19.57M	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	61.49M	59.2M	59.2M	59.02M	59.02M	58.91M	58.58M	58.34M	55.05M	43.01M	42.79M	42.73M	39.95M	40.68M	45.75M	45.61M	44.87M	44.43M	43.52M	43.44M	43.3M	41.98M
Shares Outstanding (Diluted)	61.49M	59.2M	59.2M	59.02M	59.02M	58.91M	58.58M	58.34M	55.05M	43.01M	42.79M	42.73M	39.95M	40.68M	45.75M	45.61M	46.38M	44.43M	43.64M	43.44M	43.3M	41.98M
EPS (Basic)	-0.81	-0.84	-0.86	-0.86	-1.19	-0.82	-0.81	-0.70	-0.76	-0.86	-0.56	-0.92	-0.81	-1.42	-0.59	-0.54	3.90	-0.27	-0.74	-0.40	-0.36	0
EPS (Diluted)	-0.81	-0.84	-0.86	-0.86	-1.19	-0.82	-0.81	-0.70	-0.76	-0.86	-0.56	-0.92	-0.81	-1.42	-0.59	-0.54	3.77	-0.27	-0.74	-0.40	-0.36	0
EBITDA	-53.63M	-53.62M	-50.63M	-50.53M	-69.98M	-48.43M	-47.45M	-40.48M	-41.95M	-37.26M	-39.61M	-44.72M	-32.13M	-58.07M	-28.89M	-27.4M	-37.09M	-32.45M	-34.19M	-18.25M	-16.43M	1.39M
EBIT	-53.7M	-53.7M	-50.71M	-50.61M	-70.06M	-48.5M	-47.53M	-40.56M	-42.03M	-37.34M	-39.69M	-44.8M	-32.21M	-58.14M	-28.95M	-27.41M	-37.11M	-32.46M	-34.21M	-18.26M	-16.44M	1.37M
Depreciation & Amortization	79K	79K	79K	79K	77K	76K	77K	76K	77K	76K	77K	80K	81K	72K	59K	9K	12K	13K	12K	13K	13K	15K